Australia’s MGC Pharmaceuticals looks to the US OTC market to fuel growth
The company is offering its shares on the OTCQB venture market Australia-based MGC Pharmaceuticals is concentrating on international expansion. The biopharma company produces treatments for dementia and epilepsy that include